rs28371702

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000106.6(CYP2D6):​c.181-41T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.60 ( 24907 hom., cov: 16)
Exomes 𝑓: 0.55 ( 218680 hom. )
Failed GnomAD Quality Control

Consequence

CYP2D6
NM_000106.6 intron

Scores

1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.36

Publications

14 publications found
Variant links:
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
NDUFA6-DT (HGNC:45273): (NDUFA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.731 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2D6NM_000106.6 linkc.181-41T>G intron_variant Intron 1 of 8 ENST00000645361.2 NP_000097.3 P10635-1C1ID52Q5Y7H2
CYP2D6NM_001025161.3 linkc.181-41T>G intron_variant Intron 1 of 7 NP_001020332.2 P10635-2Q5Y7H2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2D6ENST00000645361.2 linkc.181-41T>G intron_variant Intron 1 of 8 NM_000106.6 ENSP00000496150.1 P10635-1

Frequencies

GnomAD3 genomes
AF:
0.605
AC:
78874
AN:
130452
Hom.:
24871
Cov.:
16
show subpopulations
Gnomad AFR
AF:
0.738
Gnomad AMI
AF:
0.537
Gnomad AMR
AF:
0.504
Gnomad ASJ
AF:
0.645
Gnomad EAS
AF:
0.712
Gnomad SAS
AF:
0.555
Gnomad FIN
AF:
0.507
Gnomad MID
AF:
0.632
Gnomad NFE
AF:
0.560
Gnomad OTH
AF:
0.590
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.554
AC:
747831
AN:
1348904
Hom.:
218680
Cov.:
32
AF XY:
0.555
AC XY:
369697
AN XY:
666704
show subpopulations
African (AFR)
AF:
0.750
AC:
23463
AN:
31286
American (AMR)
AF:
0.432
AC:
15410
AN:
35658
Ashkenazi Jewish (ASJ)
AF:
0.656
AC:
16272
AN:
24804
East Asian (EAS)
AF:
0.627
AC:
22879
AN:
36502
South Asian (SAS)
AF:
0.542
AC:
42783
AN:
78982
European-Finnish (FIN)
AF:
0.504
AC:
18795
AN:
37298
Middle Eastern (MID)
AF:
0.597
AC:
2457
AN:
4116
European-Non Finnish (NFE)
AF:
0.549
AC:
573234
AN:
1043652
Other (OTH)
AF:
0.575
AC:
32538
AN:
56606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
14816
29633
44449
59266
74082
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16028
32056
48084
64112
80140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.605
AC:
78946
AN:
130546
Hom.:
24907
Cov.:
16
AF XY:
0.602
AC XY:
37797
AN XY:
62832
show subpopulations
African (AFR)
AF:
0.738
AC:
24840
AN:
33646
American (AMR)
AF:
0.504
AC:
6586
AN:
13074
Ashkenazi Jewish (ASJ)
AF:
0.645
AC:
2103
AN:
3258
East Asian (EAS)
AF:
0.711
AC:
3346
AN:
4706
South Asian (SAS)
AF:
0.555
AC:
2019
AN:
3640
European-Finnish (FIN)
AF:
0.507
AC:
4408
AN:
8686
Middle Eastern (MID)
AF:
0.643
AC:
180
AN:
280
European-Non Finnish (NFE)
AF:
0.560
AC:
34018
AN:
60714
Other (OTH)
AF:
0.583
AC:
1021
AN:
1750
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1221
2442
3664
4885
6106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.535
Hom.:
3213
Bravo
AF:
0.612

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.6
PhyloP100
-2.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28371702; hg19: chr22-42525952; API